A black triangle to medicines undergoing additional monitoring

An inverted triangle ‘▼’ is the new symbol to identify medicines undergoing additional safety monitoring.


DRA Pharmaco-chemical Team keeps growing

DRA has further strengthened its Pharmaco-chemical Team with the appointment of a new Regulatory Expert.


Problems with preparing a SmPC?

European Medicines Agency has published a training video to give guidance on how to prepare and review summaries of product characteristics (SmPCs) for human medicines.


Thanks to all our visitors!

We would like to thank everyone who visited our booth at the 2nd Pharmacovigilance Conference in Helsinki.


DRA has a booth at the 2nd Nordic Pharmacovigilance Conference in Helsinki on 29 January

We welcome everyone to drop by at our booth for a chat and have a closer look at our services.


We are more than 50!

The year 2013 started in a significant way for us as we became a company with more than 50 employees by getting three new experts in our team.


DRA wishes you Merry Christmas and a Happy New Year!

DRA will be open normally over the Christmas period only closing on the public holidays.


Black symbol for products under additional monitoring

Next year a black symbol must be included in the SPC and PIL for medicinal products that are under additional monitoring, for example those containing a new pharmaceutical ingredient.


News on Marketing Compliance from Denmark

Eija Kinos attended the seminar on Scandinavian Marketing Compliance organised by Läkemedelsakademin on 5-6 December in Denmark.


News on electronic submissions from Sweden

DRA Consulting was represented by Hanna Saari and Anna Rontu during the seminar on e-submissions on 28 November in Sweden.


Eeva-Liisa Rahko to attend Veterinary Medicines Seminar in Sweden

See you at Veterinary Medicines Seminar


Kaija Rinne to attend Market Access Conference in Denmark

Kaija Rinne will attend the conference Market Access in the Nordic Region on 21-23 November in Denmark.

1 11 12 13 14 15